ACR Meeting Abstracts

ACR Meeting Abstracts

  • Meetings
    • ACR Convergence 2025
    • ACR Convergence 2024
    • ACR Convergence 2023
    • 2023 ACR/ARP PRSYM
    • ACR Convergence 2022
    • ACR Convergence 2021
    • 2020-2009 Meetings
    • Download Abstracts
  • Keyword Index
  • Advanced Search
  • Your Favorites
    • Favorites
    • Login
    • View and print all favorites
    • Clear all your favorites
  • ACR Meetings

ACR Convergence 2025

October 24-29, 2025. Chicago, Illinois.

View by Number View by Title View Sessions

Tuesday, October 28, 2025

10:30AM-12:30PM
Abstract Number: 2059
Autoantibody Patterns in Myositis Immunoblot Testing: A Retrospective Study inInflammatory Myopathies and Connective Tissue Diseases (2017–2023)
(2052–2078) Muscle Biology, Myositis & Myopathies – Basic & Clinical Science Poster III
10:30AM-12:30PM
Abstract Number: 2492
Autoantibody Profiles and Disease Trajectories in Early Systemic Sclerosis: Insights from a Prospective Cohort
(2470–2503) Systemic Sclerosis & Related Disorders – Clinical Poster III
10:30AM-12:30PM
Abstract Number: 2295
Autoantibody Profiles and Their Association with Organ Involvement in Primary Sjögren’s Syndrome: Insights from ESSDAI
(2290–2304) Sjögren’s Disease – Basic & Clinical Science Poster III: Treatment and Trial Outcome Measures
10:30AM-12:30PM
Abstract Number: 2382
Autoimmune Hemolytic Anemia in SLE: A Real-World National Cohort Study
(2377–2436) Systemic Lupus Erythematosus – Diagnosis, Manifestations, & Outcomes Poster III
10:30AM-12:30PM
Abstract Number: 2471
Automated Feedback and Quality Control in Nailfold Capillaroscopy: A Tool for Clinical and Educational Use
(2470–2503) Systemic Sclerosis & Related Disorders – Clinical Poster III
10:30AM-12:30PM
Abstract Number: 2172
Automating the Curation and Summarization of Rheumatology Fellowship Applications using Generative AI Agents and Transformer Models
(2159–2194) Professional Education Poster
10:30AM-12:30PM
Abstract Number: 2505
Avacopan is Not Associated With An Increased Risk of Infection Compared to Glucocorticoids in Patients with ANCA-Associated Vasculitis
(2504–2523) Vasculitis – ANCA-Associated Poster III
10:30AM-12:30PM
Abstract Number: 2213
Awareness Regarding Contraceptive Measures, Drug Usage And Factors Affecting Pregnancy Among Patients With Autoimmune Rheumatic Diseases
(2195–2226) Reproductive Issues in Rheumatic Disorders Posters
10:30AM-10:45AM
Abstract Number: 1754
B3GNT2 Regulates Integrin β3 Glycosylation and Th17/Treg Imbalance in Axial Spondyloarthritis Pathogenesis
Abstracts: Spondyloarthritis Including Psoriatic Arthritis – Basic Science (1752–1757)
10:30AM-12:30PM
Abstract Number: 2346
Back in Action: Six Months of Biological Therapy Improve Sexual Function in Men with Ankylosing Spondylitis
(2338–2376) Spondyloarthritis Including Psoriatic Arthritis – Treatment Poster III
10:30AM-12:30PM
Abstract Number: 1863
Bag3 in systemic sclerosis: possible therapeutic target and biomarker for pulmonary fibrosis
(1855–1876) Systemic Sclerosis & Related Disorders – Basic Science Poster II
10:30AM-12:30PM
Abstract Number: 2017
Baseline and 2-year Follow-up of Pulmonary Function Among CTD-ILD Subtypes
(2015–2051) Miscellaneous Rheumatic & Inflammatory Diseases Poster III
10:30AM-12:30PM
Abstract Number: 1975
Baseline QTc Screening and Monitoring Among SARD Patients with High Cardiovascular Risks on Hydroxychloroquine Based on 2021 ACR Consensus: A Quality Improvement Project
(1972–1989) Measures & Measurement of Healthcare Quality Poster II
10:30AM-12:30PM
Abstract Number: 2028
Behçet’s Syndrome Beyond Endemic Borders: A 24-Year Longitudinal Analysis of Mortality in a Diverse South American Cohort
(2015–2051) Miscellaneous Rheumatic & Inflammatory Diseases Poster III
10:30AM-12:30PM
Abstract Number: 2535
Behçet’s syndrome: distinct features in 344 pediatric and adult patients in a non-endemic region
(2524–2546) Vasculitis – Non-ANCA-Associated & Related Disorders Poster III
  • «Previous Page
  • 1
  • …
  • 5
  • 6
  • 7
  • 8
  • 9
  • …
  • 62
  • Next Page»
Advanced Search

Your Favorites

You can save and print a list of your favorite abstracts during your browser session by clicking the “Favorite” button at the bottom of any abstract. View your favorites »

Embargo Policy

All abstracts accepted to ACR Convergence are under media embargo once the ACR has notified presenters of their abstract’s acceptance. They may be presented at other meetings or published as manuscripts after this time but should not be discussed in non-scholarly venues or outlets. The following embargo policies are strictly enforced by the ACR.

Accepted abstracts are made available to the public online in advance of the meeting and are published in a special online supplement of our scientific journal, Arthritis & Rheumatology. Information contained in those abstracts may not be released until the abstracts appear online. In an exception to the media embargo, academic institutions, private organizations, and companies with products whose value may be influenced by information contained in an abstract may issue a press release to coincide with the availability of an ACR abstract on the ACR website. However, the ACR continues to require that information that goes beyond that contained in the abstract (e.g., discussion of the abstract done as part of editorial news coverage) is under media embargo until 10:00 AM CT on October 25. Journalists with access to embargoed information cannot release articles or editorial news coverage before this time. Editorial news coverage is considered original articles/videos developed by employed journalists to report facts, commentary, and subject matter expert quotes in a narrative form using a variety of sources (e.g., research, announcements, press releases, events, etc.).

Violation of this policy may result in the abstract being withdrawn from the meeting and other measures deemed appropriate. Authors are responsible for notifying colleagues, institutions, communications firms, and all other stakeholders related to the development or promotion of the abstract about this policy. If you have questions about the ACR abstract embargo policy, please contact ACR abstracts staff at [email protected].

Wiley

  • Online Journal
  • Privacy Policy
  • Permissions Policies
  • Cookie Preferences

© Copyright 2025 American College of Rheumatology